For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Clover Health Investments Corp (NASDAQ: CLOV) closed at $4.41 in the last session, down -1.12% from day before closing price of $4.46. In other words, the price has decreased by -$1.12 from its previous closing price. On the day, 3.49 million shares were traded.
Ratios:
We take a closer look at CLOV’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on December 17, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On October 07, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $4.
Cowen Upgraded its Underperform to Market Perform on February 02, 2022, whereas the target price for the stock was revised from $7 to $3.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Garipalli Vivek bought 531,700 shares for $1.88 per share. The transaction valued at 999,596 led to the insider holds 1,409,267 shares of the business.
Garipalli Vivek bought 877,567 shares of CLOV for $1,000,426 on Jun 17 ’24. The Director now owns 877,567 shares after completing the transaction at $1.14 per share. On May 16 ’24, another insider, Loengard Anna U, who serves as the Director of the company, bought 17,085 shares for $0.96 each. As a result, the insider paid 16,372 and bolstered with 15,600 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.44 while its Price-to-Book (P/B) ratio in mrq is 6.23.
Stock Price History:
Over the past 52 weeks, CLOV has reached a high of $4.87, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 15.52%, while the 200-Day Moving Average is calculated to be 61.42%.
Shares Statistics:
A total of 394.44M shares are outstanding, with a floating share count of 376.49M. Insiders hold about 24.87% of the company’s shares, while institutions hold 18.56% stake in the company.
Earnings Estimates
Clover Health Investments Corp (CLOV) is currently under the scrutiny of 2.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.03 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.12 and -$0.12 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is -$0.1, with 2.0 analysts recommending between -$0.07 and -$0.14.
Revenue Estimates
According to 4 analysts, the current quarter’s revenue is expected to be $346.92M. It ranges from a high estimate of $353.22M to a low estimate of $343.62M. As of the current estimate, Clover Health Investments Corp’s year-ago sales were $510.25MFor the next quarter, 4 analysts are estimating revenue of $397.59M. There is a high estimate of $419.24M for the next quarter, whereas the lowest estimate is $378.13M.
A total of 4 analysts have provided revenue estimates for CLOV’s current fiscal year. The highest revenue estimate was $1.39B, while the lowest revenue estimate was $1.38B, resulting in an average revenue estimate of $1.38B. In the same quarter a year ago, actual revenue was $2.03BBased on 4 analysts’ estimates, the company’s revenue will be $1.59B in the next fiscal year. The high estimate is $1.71B and the low estimate is $1.52B.
